内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2018 台湾2型糖尿病合并心血管疾病患者药物管理共识

2018-02-13 台湾心脏病学会 J Chin Med Assoc. 2018 Feb 13.

2型糖尿病心血管疾病药物管理

2018年2月，台湾心脏病学会(TSOC)联合中国糖尿病协会（台湾）共同发布了2型糖尿病合并心血管疾病患者药物管理共识。该共识明确了2型糖尿病患者心血管疾病的治疗。全文共包含5部分内容，分别为：糖尿病患者高血压的治疗，糖尿病患者冠心病的治疗，糖尿病患者3期慢性肾病的治疗，具有卒中病史的糖尿病患者的治疗以及糖尿病患者心衰的治疗。

中文标题：

2018 台湾2型糖尿病合并心血管疾病患者药物管理共识

英文标题：

2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases.

发布机构：

台湾心脏病学会

发布日期：

2018-02-13

简要介绍：

2018年2月，台湾心脏病学会(TSOC)联合中国糖尿病协会（台湾）共同发布了2型糖尿病合并心血管疾病患者药物管理共识。该共识明确了2型糖尿病患者心血管疾病的治疗。全文共包含5部分内容，分别为：糖尿病患者高血压的治疗，糖尿病患者冠心病的治疗，糖尿病患者3期慢性肾病的治疗，具有卒中病史的糖尿病患者的治疗以及糖尿病患者心衰的治疗。

 

拓展指南：与糖尿病相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 台湾2型糖尿病合并心血管疾病患者药物管理共识)] GetToolGuiderByIdResponse(projectId=1, id=549471c001558936, title=2018 台湾2型糖尿病合并心血管疾病患者药物管理共识, enTitle=2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases., guiderFrom=J Chin Med Assoc. 2018 Feb 13., authorId=null, author=, summary=2018年2月，台湾心脏病学会(TSOC)联合中国糖尿病协会（台湾）共同发布了2型糖尿病合并心血管疾病患者药物管理共识。该共识明确了2型糖尿病患者心血管疾病的治疗。全文共包含5部分内容，分别为：糖尿病患者高血压的治疗，糖尿病患者冠心病的治疗，糖尿病患者3期慢性肾病的治疗，具有卒中病史的糖尿病患者的治疗以及糖尿病患者心衰的治疗。 , cover=, journalId=null, articlesId=null, associationId=267, associationName=台湾心脏病学会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Feb 13 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2018年2月，台湾心脏病学会(TSOC)联合中国糖尿病协会（台湾）共同发布了2型糖尿病合并心血管疾病患者药物管理共识。该共识明确了2型糖尿病患者心血管疾病的治疗。全文共包含5部分内容，分别为：糖尿病患者高血压的治疗，糖尿病患者冠心病的治疗，糖尿病患者3期慢性肾病的治疗，具有卒中病史的糖尿病患者的治疗以及糖尿病患者心衰的治疗。 </P> <P> </P>拓展指南：<strong>与<font color=red>糖尿病</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=9bf971c00155ea6b" title="2018 波兰糖尿病患者管理指南" target=_blank>2018 波兰糖尿病患者管理指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d1a4e1c00155a18b" title="2018 年ADA糖尿病医学诊疗标准解读" target=_blank>2018 年ADA糖尿病医学诊疗标准解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=10cbc1c001552673" title="糖尿病足介入综合诊治临床指南（第4版）" target=_blank>糖尿病足介入综合诊治临床指南（第4版）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=769dc1c0015508d1" title="2018 ACOG实践简报：妊娠期糖尿病（No.190）-临床更新" target=_blank>2018 ACOG实践简报：妊娠期糖尿病（No.190）-临床更新</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=761871c0015506fd" title="中国2型糖尿病自我管理处方专家共识 （2017年版）" target=_blank>中国2型糖尿病自我管理处方专家共识 （2017年版）</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E7%B3%96%E5%B0%BF%E7%97%85" target=_blank>有关糖尿病更多指南</a></ul>, tagList=[TagDto(tagId=2052, tagName=2型糖尿病), TagDto(tagId=2529, tagName=心血管疾病), TagDto(tagId=66473, tagName=药物管理)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6507, appHits=326, showAppHits=0, pcHits=4791, showPcHits=1924, likes=179, shares=4, comments=6, approvalStatus=1, publishedTime=Sat Feb 24 20:22:18 CST 2018, publishedTimeString=2018-02-13, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Feb 24 20:22:18 CST 2018, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 00:44:30 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 台湾2型糖尿病合并心血管疾病患者药物管理共识)])
2018 台湾2型糖尿病合并心血管疾病患者药物管理共识
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=291275, encodeId=c4d02912e530, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Feb 27 06:55:07 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290975, encodeId=e3832909e554, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Mon Feb 26 06:36:48 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290864, encodeId=0dd629086492, content=不错的文章.值得拥有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun Feb 25 22:08:31 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290811, encodeId=94222908112d, content=学习.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sun Feb 25 12:41:14 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290604, encodeId=2b5a29060491, content=2018年2月.台湾心脏病学会(TSOC)联合中国糖尿病协会(台湾)共同发布了2型糖尿病合并心血管疾病患者药物管理共识.该共识明确了2型糖尿病患者心血管疾病的治疗.全文共包含5部分内容.分别为:糖尿病患者高血压的治疗.糖尿病患者冠心病的治疗.糖尿病患者3期慢性肾病的治疗.具有卒中病史的糖尿病患者的治疗以及糖尿病患者心衰的治疗., beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Feb 24 22:07:49 CST 2018, time=2018-02-24, status=1, ipAttribution=)]
    2018-02-27 1209e435m98(暂无昵称)

    学习了.谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=291275, encodeId=c4d02912e530, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Feb 27 06:55:07 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290975, encodeId=e3832909e554, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Mon Feb 26 06:36:48 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290864, encodeId=0dd629086492, content=不错的文章.值得拥有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun Feb 25 22:08:31 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290811, encodeId=94222908112d, content=学习.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sun Feb 25 12:41:14 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290604, encodeId=2b5a29060491, content=2018年2月.台湾心脏病学会(TSOC)联合中国糖尿病协会(台湾)共同发布了2型糖尿病合并心血管疾病患者药物管理共识.该共识明确了2型糖尿病患者心血管疾病的治疗.全文共包含5部分内容.分别为:糖尿病患者高血压的治疗.糖尿病患者冠心病的治疗.糖尿病患者3期慢性肾病的治疗.具有卒中病史的糖尿病患者的治疗以及糖尿病患者心衰的治疗., beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Feb 24 22:07:49 CST 2018, time=2018-02-24, status=1, ipAttribution=)]
    2018-02-26 半夏微凉

    学习了谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=291275, encodeId=c4d02912e530, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Feb 27 06:55:07 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290975, encodeId=e3832909e554, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Mon Feb 26 06:36:48 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290864, encodeId=0dd629086492, content=不错的文章.值得拥有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun Feb 25 22:08:31 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290811, encodeId=94222908112d, content=学习.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sun Feb 25 12:41:14 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290604, encodeId=2b5a29060491, content=2018年2月.台湾心脏病学会(TSOC)联合中国糖尿病协会(台湾)共同发布了2型糖尿病合并心血管疾病患者药物管理共识.该共识明确了2型糖尿病患者心血管疾病的治疗.全文共包含5部分内容.分别为:糖尿病患者高血压的治疗.糖尿病患者冠心病的治疗.糖尿病患者3期慢性肾病的治疗.具有卒中病史的糖尿病患者的治疗以及糖尿病患者心衰的治疗., beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Feb 24 22:07:49 CST 2018, time=2018-02-24, status=1, ipAttribution=)]
    2018-02-25 1e1b8538m79(暂无匿称)

    不错的文章.值得拥有

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=291275, encodeId=c4d02912e530, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Feb 27 06:55:07 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290975, encodeId=e3832909e554, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Mon Feb 26 06:36:48 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290864, encodeId=0dd629086492, content=不错的文章.值得拥有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun Feb 25 22:08:31 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290811, encodeId=94222908112d, content=学习.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sun Feb 25 12:41:14 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290604, encodeId=2b5a29060491, content=2018年2月.台湾心脏病学会(TSOC)联合中国糖尿病协会(台湾)共同发布了2型糖尿病合并心血管疾病患者药物管理共识.该共识明确了2型糖尿病患者心血管疾病的治疗.全文共包含5部分内容.分别为:糖尿病患者高血压的治疗.糖尿病患者冠心病的治疗.糖尿病患者3期慢性肾病的治疗.具有卒中病史的糖尿病患者的治疗以及糖尿病患者心衰的治疗., beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Feb 24 22:07:49 CST 2018, time=2018-02-24, status=1, ipAttribution=)]
    2018-02-25 惠映实验室

    学习.谢谢分享.

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=291275, encodeId=c4d02912e530, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Feb 27 06:55:07 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290975, encodeId=e3832909e554, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Mon Feb 26 06:36:48 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290864, encodeId=0dd629086492, content=不错的文章.值得拥有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun Feb 25 22:08:31 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290811, encodeId=94222908112d, content=学习.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sun Feb 25 12:41:14 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290604, encodeId=2b5a29060491, content=2018年2月.台湾心脏病学会(TSOC)联合中国糖尿病协会(台湾)共同发布了2型糖尿病合并心血管疾病患者药物管理共识.该共识明确了2型糖尿病患者心血管疾病的治疗.全文共包含5部分内容.分别为:糖尿病患者高血压的治疗.糖尿病患者冠心病的治疗.糖尿病患者3期慢性肾病的治疗.具有卒中病史的糖尿病患者的治疗以及糖尿病患者心衰的治疗., beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Feb 24 22:07:49 CST 2018, time=2018-02-24, status=1, ipAttribution=)]
    2018-02-24 有备才能无患

    2018年2月.台湾心脏病学会(TSOC)联合中国糖尿病协会(台湾)共同发布了2型糖尿病合并心血管疾病患者药物管理共识.该共识明确了2型糖尿病患者心血管疾病的治疗.全文共包含5部分内容.分别为:糖尿病患者高血压的治疗.糖尿病患者冠心病的治疗.糖尿病患者3期慢性肾病的治疗.具有卒中病史的糖尿病患者的治疗以及糖尿病患者心衰的治疗.

    0

相关指南

2型糖尿病合并血脂异常的他汀类药物治疗专家共识（基层版）

中国医师协会全科医师分会 · 2017-12-30

2018 AACE/ACE共识声明：2型糖尿病综合管理方案

美国临床内分泌医师学会(AACE,American Association of Clinical Endocrinologists) · 2018-01-10

2017 KDA立场声明：胰高血糖素样肽-1受体激动剂治疗2型糖尿病

韩国糖尿病协会(KDA,Korean Diabetes Association) · 2017-12-15

2017 SIGN国家临床指南：2型糖尿病患者血糖控制的药物管理（154）

苏格兰校际指南网络(SIGN,Scottish Intercollegiate Guidelines Network) · 2017-11-30

中国2型糖尿病合并血脂异常防治专家共识（2017年修订版）

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2017-11-28

关于2型糖尿病合并慢性肾脏病患者应用胰岛素治疗的专家指导建议

中国内分泌相关专家小组（统称） · 2017-10-30